Connection

Heather Boger to Mice

This is a "connection" page, showing publications Heather Boger has written about Mice.
Connection Strength

0.615
  1. Short-term effects of an endotoxin on substantia nigra dopamine neurons. Brain Res. 2014 Apr 04; 1557:164-70.
    View in: PubMed
    Score: 0.051
  2. Glial cell-line derived neurotrophic factor (GDNF) replacement attenuates motor impairments and nigrostriatal dopamine deficits in 12-month-old mice with a partial deletion of GDNF. Pharmacol Biochem Behav. 2013 Mar; 104:10-9.
    View in: PubMed
    Score: 0.047
  3. Prenatal LPS increases inflammation in the substantia nigra of Gdnf heterozygous mice. Brain Pathol. 2011 May; 21(3):330-48.
    View in: PubMed
    Score: 0.041
  4. Enhanced dopamine transporter activity in middle-aged Gdnf heterozygous mice. Neurobiol Aging. 2012 Feb; 33(2):427.e1-14.
    View in: PubMed
    Score: 0.041
  5. Effects of brain-derived neurotrophic factor on dopaminergic function and motor behavior during aging. Genes Brain Behav. 2011 Mar; 10(2):186-98.
    View in: PubMed
    Score: 0.041
  6. Minocycline restores striatal tyrosine hydroxylase in GDNF heterozygous mice but not in methamphetamine-treated mice. Neurobiol Dis. 2009 Mar; 33(3):459-66.
    View in: PubMed
    Score: 0.036
  7. Differential effects of the dopamine neurotoxin MPTP in animals with a partial deletion of the GDNF receptor, GFR alpha1, gene. Brain Res. 2008 Nov 19; 1241:18-28.
    View in: PubMed
    Score: 0.035
  8. Long-term consequences of methamphetamine exposure in young adults are exacerbated in glial cell line-derived neurotrophic factor heterozygous mice. J Neurosci. 2007 Aug 15; 27(33):8816-25.
    View in: PubMed
    Score: 0.033
  9. A partial GDNF depletion leads to earlier age-related deterioration of motor function and tyrosine hydroxylase expression in the substantia nigra. Exp Neurol. 2006 Dec; 202(2):336-47.
    View in: PubMed
    Score: 0.030
  10. Spinophilin-deficient mice are protected from diet-induced obesity and insulin resistance. Am J Physiol Endocrinol Metab. 2020 08 01; 319(2):E354-E362.
    View in: PubMed
    Score: 0.020
  11. Calpain mediated expansion of CD4+ cytotoxic T cells in rodent models of Parkinson's disease. Exp Neurol. 2020 08; 330:113315.
    View in: PubMed
    Score: 0.020
  12. Inhibitory designer receptors aggravate memory loss in a mouse model of down syndrome. Neurobiol Dis. 2020 02; 134:104616.
    View in: PubMed
    Score: 0.019
  13. Diet-induced insulin resistance elevates hippocampal glutamate as well as VGLUT1 and GFAP expression in A?PP/PS1 mice. J Neurochem. 2019 01; 148(2):219-237.
    View in: PubMed
    Score: 0.018
  14. 5-HT1F receptor-mediated mitochondrial biogenesis for the treatment of Parkinson's disease. Br J Pharmacol. 2018 01; 175(2):348-358.
    View in: PubMed
    Score: 0.017
  15. Enhanced Cognition and Hypoglutamatergic Signaling in a Growth Hormone Receptor Knockout Mouse Model of Successful Aging. J Gerontol A Biol Sci Med Sci. 2017 03 01; 72(3):329-337.
    View in: PubMed
    Score: 0.016
  16. Accumbens nNOS Interneurons Regulate Cocaine Relapse. J Neurosci. 2017 01 25; 37(4):742-756.
    View in: PubMed
    Score: 0.016
  17. Effects of fingolimod administration in a genetic model of cognitive deficits. J Neurosci Res. 2017 05; 95(5):1174-1181.
    View in: PubMed
    Score: 0.015
  18. Cognitive Impairment, Neuroimaging, and Alzheimer Neuropathology in Mouse Models of Down Syndrome. Curr Alzheimer Res. 2016; 13(1):35-52.
    View in: PubMed
    Score: 0.015
  19. Designer receptors enhance memory in a mouse model of Down syndrome. J Neurosci. 2015 Jan 28; 35(4):1343-53.
    View in: PubMed
    Score: 0.014
  20. Estrogen receptor alpha deficiency protects against development of cognitive impairment in murine lupus. J Neuroinflammation. 2014 Dec 16; 11:171.
    View in: PubMed
    Score: 0.014
  21. Evidence of altered age-related brain cytoarchitecture in mouse models of down syndrome: a diffusional kurtosis imaging study. Magn Reson Imaging. 2015 May; 33(4):437-47.
    View in: PubMed
    Score: 0.014
  22. Three-dimensional rodent motion analysis and neurodegenerative disorders. J Neurosci Methods. 2014 Jul 15; 231:31-7.
    View in: PubMed
    Score: 0.013
  23. A noradrenergic lesion exacerbates neurodegeneration in a Down syndrome mouse model. J Alzheimers Dis. 2011; 23(3):471-89.
    View in: PubMed
    Score: 0.010
  24. Effects of long-term memantine on memory and neuropathology in Ts65Dn mice, a model for Down syndrome. Behav Brain Res. 2011 Aug 10; 221(2):610-22.
    View in: PubMed
    Score: 0.010
  25. The nigrostriatal dopamine system of aging GFRalpha-1 heterozygous mice: neurochemistry, morphology and behavior. Eur J Neurosci. 2008 Oct; 28(8):1557-68.
    View in: PubMed
    Score: 0.009
  26. Effects of glial cell line-derived neurotrophic factor deletion on ventral mesencephalic organotypic tissue cultures. Brain Res. 2007 Feb 16; 1133(1):10-9.
    View in: PubMed
    Score: 0.008
  27. Partial deletion of glial cell line-derived neurotrophic factor (GDNF) in mice: Effects on sucrose reward and striatal GDNF concentrations. Brain Res. 2006 Jan 12; 1068(1):257-60.
    View in: PubMed
    Score: 0.007
  28. Glial cell line-derived neurotrophic factor is essential for neuronal survival in the locus coeruleus-hippocampal noradrenergic pathway. Neuroscience. 2004; 124(1):137-46.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.